EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Lactate‐Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM‐Dependent Mitochondrial Fatty Acid Synthesis

Jingsheng Yuan iD, Mingyang Yang, Zhenru Wu, Jun Wu, Kejie Zheng, JiaGuo Wang, Qiwen Zeng, Menglin Chen, Tao Lv, Yujun Shi, Jiayin Yang iD, Jian Yang iD

Advanced Science · 2025-03 · 12 (11)

DOI: 10.1002/advs.202414141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.01.2025. Verfasst von Jingsheng Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplant Center, Transplant Center, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Ferroptosis, Fatty Acids, Liver. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recipients often suffer from hyperlactatemia during liver transplantation (LT), but whether hyperlactatemia exacerbates hepatic ischemia‐reperfusion injury (IRI) after donor liver implantation remains unclear. Here, the role of hyperlactatemia in hepatic IRI is explored. In this work, hyperlactatemia is found to exacerbate ferroptosis during hepatic IRI. Lactate‐primed lysine acetyltransferase 8 (KAT8) is determined to directly lactylate mitochondrial phosphoenolpyruvate carboxykinase 2 (PCK2) at Lys100 and augments PCK2 kinase activity. By using gene‐edited mice, evidence indicating that PCK2 exacerbates hepatic ferroptosis during IRI is generated. Mechanistically, PCK2 lactylate at Lys100 acts as a critical inducer of ferroptosis during IRI by competitively inhibiting the Parkin‐mediated polyubiquitination of 3‐oxoacyl‐ACP synthase (OXSM), thereby leading to metabolic remodeling of mitochondrial fatty acid synthesis (mtFAS) and the potentiation of oxidative phosphorylation and the tricarboxylic acid cycle. More importantly, targeting PCK2 is demonstrated to markedly ameliorate hyperlactatemia‐mediated ferroptosis during hepatic IRI. Collectively, the findings support the use of therapeutics targeting PCK2 to suppress hepatic ferroptosis and IRI in patients with hyperlactatemia during LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryFerroptosisFatty AcidsLiverLactic AcidAcetyltransferasesAnimalsMiceMitochondriaHumansMaleMice, Inbred C57BL

Stichwörter der Autor:innen

ferroptosishepatic ischemia‒reperfusion injurylactatelactylationmetabolic reprogrammingmitochondrial fatty acid synthesisphosphoenolpyruvate carboxykinase 2

Substanzen

Fatty AcidsLactic AcidAcetyltransferases

Autor:innen und Institutionen

  • Liver Transplant Center, Transplant Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Institute of Organ Transplantation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Emergency and Critical Care Medicine, West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu, 610041, China.
  • Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu, 610041, China.

ORCID-Profile: Jingsheng Yuan, Jiayin Yang, Jian Yang

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • China Postdoctoral Science Foundation
  • Sichuan Province Science and Technology Support Program
  • Science and Technology Department of Sichuan Province
  • Postdoctor Research Fund of West China Hospital, Sichuan University
  • Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation

Zitieren

APA

Yuan, J., Yang, M., Wu, Z., Wu, J., Zheng, K., Wang, J., Zeng, Q., Chen, M., Lv, T., Shi, Y., Yang, J., & Yang, J. (2025). The Lactate‐Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM‐Dependent Mitochondrial Fatty Acid Synthesis. Advanced Science, 12(11). https://doi.org/10.1002/advs.202414141

Vancouver

Yuan J, Yang M, Wu Z, Wu J, Zheng K, Wang J, et al. The Lactate‐Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM‐Dependent Mitochondrial Fatty Acid Synthesis. Advanced Science. 2025;12(11). doi:10.1002/advs.202414141

BibTeX
@article{Yuan2025,
  author = {Yuan, Jingsheng and Yang, Mingyang and Wu, Zhenru and Wu, Jun and Zheng, Kejie and Wang, JiaGuo and Zeng, Qiwen and Chen, Menglin and Lv, Tao and Shi, Yujun and Yang, Jiayin and Yang, Jian},
  title = {The Lactate‐Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM‐Dependent Mitochondrial Fatty Acid Synthesis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {11},
  doi = {10.1002/advs.202414141}
}
Kostenlos starten →